{"id":484376,"date":"2021-04-29T08:34:20","date_gmt":"2021-04-29T12:34:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/"},"modified":"2021-04-29T08:34:20","modified_gmt":"2021-04-29T12:34:20","slug":"albireo-to-report-first-quarter-2021-financial-results-on-may-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/","title":{"rendered":"Albireo to Report First Quarter 2021 Financial Results on May 6"},"content":{"rendered":"<h2>\nConference call and webcast to be held at 10:00 a.m. ET<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">BOSTON, April  29, 2021  (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at\u00a010:00 a.m. ET on\u00a0May 6, 2021, to provide a business update and review the company\u2019s financial results for the first quarter ended March 31, 2021.<\/p>\n<p>To access the live conference call by phone, please dial 888-599-8686 (domestic) or 323-994-2082 (international) and provide the access code 8407763. A live audio webcast will be accessible from the Media &amp; Investors page of Albireo\u2019s website,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0vfbHmnz9_tYbByv9f1OMLmw38IPsjU-b7Do-mnaPRDkoD7krwAkH6HzYMaV1IxxGWaB8LgpOggoxBhkuoGSeS4VyXUwmPzaRAkkT9dhzME=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.albireopharma.com\/<\/a>. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the start time. An archived version of the webcast will be available for replay in the Events &amp; Presentations section of the Media &amp; Investors page of Albireo\u2019s website for 3 months following the event.<\/p>\n<p>\n        <strong>About Albireo<br \/><\/strong>Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases. Albireo\u2019s lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 trials in PFIC, Alagille syndrome and biliary atresia. For PFIC, the FDA granted Priority Review and set a PDUFA goal date of July 20, 2021. In Europe, the EMA validated MAA.Odevixibat is the only IBATi granted accelerated assessment by the EMA. The Company has also initiated a Phase 1 clinical trial for A3907 to advance development in adult cholestatic liver disease, with IND-enabling studies moving ahead with A2342 for viral and cholestatic liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year. For more information on Albireo, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JzzxmSo2Z44nu2F8qFSel3GW7hvEJ3pLODD8MIlm2JxFxe4VtcAP6Xz1qUEU6DJ3IsIAzUYCgjaNSWy52fvL57AxfOvAsIW9nQShkcbcEoo=\" rel=\"nofollow noopener\" target=\"_blank\">www.albireopharma.com<\/a>.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Colleen Alabiso, 857-356-3905,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NTDqMI2JMoS0IHEYjKU0Ho1aqff8bQ-4jJI-QxvG-a43bXJRXxj5HPtRWPFE9JtShCwK3173D2FHQDLb4gmAvztZD2Y0YHAkzT7a6wAJ7oECbpfiF3zGsu5Ro-BWZPSg\" rel=\"nofollow noopener\" target=\"_blank\">colleen.alabiso@albireopharma.com<\/a><br \/>Lisa Rivero, 617-947-0899,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-GBbKxU1DdjpL7X6xqdqZBCIXuwXnULAvS5oinDCEZgJm2pqnjGqc0wdxbOZ2rUT_wRjxI2cGZKju2FxNlgQhWc-O2c4WxewSBKEyGkiUw0n-hqhCI3azHE_Ek9_vWpx\" rel=\"nofollow noopener\" target=\"_blank\">lisa.rivero@syneoshealth.com<\/a><\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Hans Vitzthum, LifeSci Advisors, LLC., 617-430-7578<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/22aa0ccc-6915-4c1c-8e75-09482d53abc5\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Conference call and webcast to be held at 10:00 a.m. ET BOSTON, April 29, 2021 (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at\u00a010:00 a.m. ET on\u00a0May 6, 2021, to provide a business update and review the company\u2019s financial results for the first quarter ended March 31, 2021. To access the live conference call by phone, please dial 888-599-8686 (domestic) or 323-994-2082 (international) and provide the access code 8407763. A live audio webcast will be accessible from the Media &amp; Investors page of Albireo\u2019s website,\u00a0https:\/\/ir.albireopharma.com\/. To ensure a timely connection to the webcast, it is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Albireo to Report First Quarter 2021 Financial Results on May 6&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-484376","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Albireo to Report First Quarter 2021 Financial Results on May 6 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Albireo to Report First Quarter 2021 Financial Results on May 6 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Conference call and webcast to be held at 10:00 a.m. ET BOSTON, April 29, 2021 (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at\u00a010:00 a.m. ET on\u00a0May 6, 2021, to provide a business update and review the company\u2019s financial results for the first quarter ended March 31, 2021. To access the live conference call by phone, please dial 888-599-8686 (domestic) or 323-994-2082 (international) and provide the access code 8407763. A live audio webcast will be accessible from the Media &amp; Investors page of Albireo\u2019s website,\u00a0https:\/\/ir.albireopharma.com\/. To ensure a timely connection to the webcast, it is &hellip; Continue reading &quot;Albireo to Report First Quarter 2021 Financial Results on May 6&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-29T12:34:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Albireo to Report First Quarter 2021 Financial Results on May 6\",\"datePublished\":\"2021-04-29T12:34:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/\"},\"wordCount\":370,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/\",\"name\":\"Albireo to Report First Quarter 2021 Financial Results on May 6 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE=\",\"datePublished\":\"2021-04-29T12:34:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Albireo to Report First Quarter 2021 Financial Results on May 6\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Albireo to Report First Quarter 2021 Financial Results on May 6 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/","og_locale":"en_US","og_type":"article","og_title":"Albireo to Report First Quarter 2021 Financial Results on May 6 - Market Newsdesk","og_description":"Conference call and webcast to be held at 10:00 a.m. ET BOSTON, April 29, 2021 (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at\u00a010:00 a.m. ET on\u00a0May 6, 2021, to provide a business update and review the company\u2019s financial results for the first quarter ended March 31, 2021. To access the live conference call by phone, please dial 888-599-8686 (domestic) or 323-994-2082 (international) and provide the access code 8407763. A live audio webcast will be accessible from the Media &amp; Investors page of Albireo\u2019s website,\u00a0https:\/\/ir.albireopharma.com\/. To ensure a timely connection to the webcast, it is &hellip; Continue reading \"Albireo to Report First Quarter 2021 Financial Results on May 6\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-29T12:34:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Albireo to Report First Quarter 2021 Financial Results on May 6","datePublished":"2021-04-29T12:34:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/"},"wordCount":370,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/","name":"Albireo to Report First Quarter 2021 Financial Results on May 6 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE=","datePublished":"2021-04-29T12:34:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTUxNiM0MTQ0MDQ0IzIwODA2NTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-first-quarter-2021-financial-results-on-may-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Albireo to Report First Quarter 2021 Financial Results on May 6"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=484376"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/484376\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=484376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=484376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=484376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}